 |
| PSID More National Attention via Hannity Show BICX Conf Call Recording Available |
|
 Hot Stock to Watch
|
Company: BioCorRx Inc. (OTCQB: BICX)
|
End of Day:
Price: 0.0821
Change (%): - 0.0166 (16.82)
Volume: 4,000 |
 |
BioCorRx, Inc. Shareholder Conference Call Audio Recording Available
Los Angeles, Oct. 20, 2014 (GLOBE NEWSWIRE) - BioCorRx, Inc. (BICX), a leader in addiction treatment, hosted its first shareholder conference call last Thursday, October 16, 2014. For investors who were unable to call in live, a full recording can be found by clicking here. During the call, the Company discussed operations through the end of the second quarter 2014 and outlook for the remainder of this year and 2015. Some highlights from the call include the following:
- the Company is cash flow positive;
- the Company eliminated approximately 1 million dollars in convertible debt;
- nine clinics are now offering the Start Fresh Program across the United States;
- four more clinics are expected to open by the end of 2014 using the Start Fresh Program;
- the Company expects the number of clinics offering the Start Fresh Program to double during 2015; and
- approximately 175 patients have been treated year to date in 2014, with that number expected to grow exponentially as more clinics open.
Continue Reading
|
 Yesterday's Top Performer
|
Company: PositiveID Corporation (OTCQB: PSID)
|
End of Day:
Price: 0.068
Change (%): + 0.016 (30.77)
Volume: 17,630,318 |
 |
PositiveID's Firefly Dx System Featured on Hannity on Fox News
PositiveID President Lyle L. Probst Discusses Capabilities of the Company's Firefly Dx Rapid Pathogen Detection System in the Fight Against Outbreaks Such as Ebola
DELRAY BEACH, Fla., Oct. 20, 2014 (GLOBE NEWSWIRE) - PositiveID Corporation (“PositiveID” or “Company”) (OTCQB:PSID), a developer of biological detection and diagnostics solutions, today announced that its President, Lyle L. Probst, was featured on Hannity on Fox News on Thursday, October 16, 2014, to discuss the Company’s Firefly Dx, a point-of-need system designed to quickly detect pathogens such as Ebola in patients and in the environment. The interview can be viewed on PositiveID’s home page at: http://www.positiveidcorp.com.
Continue Reading |
Other Small Cap News
|
Company: Medbox, Inc. (OTCQB: MDBX)
|
Medbox Appoints Mr. Doug Mitchell as Chief Financial Officer
Senior Financial Executive With 25 Years of Public Company Experience
LOS ANGELES, Oct. 20, 2014 /PRNewswire/ -- Medbox, Inc., (OTCQB:MDBX), the leading licensing, infrastructure and security specialist, patented technology provider, and partner to the cannabis industry, is pleased to announce the appointment of Mr. Doug Mitchell as its Chief Financial Officer.
Mr. Mitchell is replacing Thomas Iwanski who served Medbox as a part time CFO, and resigned to facilitate the continued development of the company with the addition of a full time CFO. Mr. Iwanski has no disagreements with management and will continue to be available to the company as a consultant. Mr. Guy Marsala, CEO of Medbox, thanked Mr. Iwanski for his service noting "the past 18 months has generated a significant and positive transformation for Medbox as the company continues to make bold moves as the leader in this high growth industry."
Continue Reading
|
Company: Cannabics Pharmaceuticals Inc. (OTCQB: CNBX)
|
Cannabics Pharmaceuticals Receives Cannabinoid R&D Lab Certification in Israel
BETHESDA, MD--(Marketwired - Oct 20, 2014) - Cannabics Pharmaceuticals Inc. (OTCQB: CNBX) announced today that it has received Government Certification from the Ministry of Health in Israel for the establishment of an advanced R&D laboratory dedicated to medical research in the field of cannabinoid science.
The stated goal of Cannabics Pharmaceuticals is to be one of the first and few companies in the world to commercialize indication specific and clinically tested cannabis-based medical products. In Accordance with this goal, Cannabics Pharmaceuticals is currently in advanced preparations for the launch of a series of rigorous and controlled clinical studies in leading medical centers in Israel where the Company's R&D division is strategically located.
Continue Reading |
Market News
|
By Patti Domm: CNBC
|
Get ready for another blast of stock volatility
Get ready for another blast of head-spinning volatility.
Following the most turbulent market week in years, some strategists are ready to call the all clear. But others say stocks could test the lows of the past week-especially if there are more signs of a weakening global economy; Ebola headlines get worse, or U.S. corporate earnings fail to deliver.
Earnings are expected from about 20 percent of the S&P 500, including tech companies, like Apple (AAPL) and Microsoft (MSFT). Big Dow stocks Boeing (BA), McDonald's (MCD), Coca-Cola ( CCE) and Caterpillar (CAT) join a parade of consumer companies, automakers and industrials. However, there is little fresh U.S. economic data with the exception of existing home sales Tuesday and CPI inflation data Wednesday. Chinese retail sales, GDP and industrial production data will be important for markets Tuesday as traders try to assess whether its economy is weakening.
Continue Reading
|
CNBC
|
IBM stumble puts markets in negative mood
U.S. stock index futures turned negative ahead of the open on Wall Street on Monday as IBM posted earnings that badly missed estimates, raising concerns that last week's volatility would continue.
Big Blue reported earnings excluding items of $3.68 a share, well below the $4.31 a share that had been expected, The stock, a Dow component, tumbled more than 7 percent in pre-market trading, following European tech giant SAP, which soured sentiment in European markets with its own disappointing earnings news.
"It's not the entirety of technology. It's not the entirety of the whole market, but a down 8 percent IBM is going to take the market down," said Art Hogan, chief market strategist at Wunderlich Securities. "It had started out a splendid Monday morning."
Continue Reading
|
  |
IMPORTANT DISCLAIMER - PLEASE READ THOROUGHLY
SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that the information is accurate. It is important for you to verify all information by your own independent research. You are receiving this message because you have agreed to receive emails from SmallCapVoice.com. You may opt out of our distribution list at any time by clicking on the "unsubscribe" link below. Link to full disclosure about compensation paid to SmallCapVoice.com, Inc. by companies featured on our website or in our e-mail communications. |
About Penny Stocks |
|
|
